Jardy Met 12.5/500mg Tab New Price
Dapagliflozin and metformin 12.5/500mg for type 2 diabetes.
Jardy Met 12.5/500mg combines dapagliflozin (SGLT2 inhibitor) and metformin for type 2 diabetes. Used when dual therapy with 12.5mg dapagliflozin and 500mg metformin per dose is appropriate. Take as directed with meals; swallow whole.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise when dual therapy is appropriate.
Ingredients
Dapagliflozin 12.5mg and metformin hydrochloride 500mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of genital and urinary infections.
Side Effects
Nausea, diarrhoea, urinary tract infections, genital mycotic infections. Rare: ketoacidosis. Report unusual tiredness or abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | CCL |
| Status | Active |
Related Products
